Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study.

Heart, lung & circulation(2023)

引用 0|浏览7
暂无评分
摘要
This study suggests that treatment with everolimus may be associated with improved glycaemic control of PTDM relative to treatment with standard doses of calcineurin inhibitor. These findings should be further studied in prospective randomised trials.
更多
查看译文
关键词
Heart transplant,Everolimus,Diabetes,Post-transplant diabetes,Calcineurin inhibitor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要